Taiwan alternatives to animal testing (TAAT)-Webinar

In Vitro Assays for Dermal Safety (PETA/PISC, IIVS)

Update	Title
2018.10.23	In Vitro Assays for Dermal Safety and Efficacy Testing for Regulatory and Non-regulatory Purposes
2018.10.29	Non-regulatory In Vitro Assays Used for Dermal Safety and Eficacy Test

Use of New Approach Methodologies (NAMs) in Risk Assessment (PETA/PISC, US EPA, PCRM)

Update	Title
2018.11.22	Use of Non-animal Methods for Skin Sensitisation Testing
2019.3.1	MPPD and CFD Modeling to Predict Dosimetry of Inhaled Substances
2019.5.7	New Approaches for Respiratory Sensitization
2019.12.1	New Approaches for Fish Toxicity Testing
2020.2.10	CATMoS: Development and Use of the Collaborative Acute Toxicity Modeling Suite
2020.6.10	Use of Non-animal Skin Sensitisation Test Methods
2020.10.7	Identification of New Approach Methodologies (NAMs) for Placement on the TSCA 4(h)(2)(C) List: A Proposed NAM Nomination Form
2021.3.16	Use of Computational and AOP-based Approaches to Inform Carcinogenicity Assessments

The Integrated Chemical Environment: Tools and Data to Support Toxicity Assessments (PETA/PISC, NICEATM)

Update	Title
2020.2.17	The Integrated Chemical Environment: Tools and Data to Support Toxicity Assessments

Testing and Assessment Methodologies- Adverse Outcome Pathway, AOP (OECD)

Update	Title
2020.4.6	Next Generation Knowledge: Adverse Outcome Pathway (AOP) Framework as a Collaborative Tool
2020.4.20	AOPs: Assembling and Evaluating Weight of Evidence and Quantitative Understanding
2020.5.4	Adverse Outcome Pathways Knowledge Base (AOP-KB) and AOP Developing Tips

Animal-free Recombinant Antibodies, rAbs (PETA/PISC, NICEATM, EURL ECVAM)

Update	Title
2020.8.3	Animal-free Antibodies Against Diseases: Rapid Response to Fight Covid-19
2020.9.28	Scientific and Economic Benefits of Animal-free Antibodies
2020.11.20	Application of Animal-free Antibodies
2020.11.20	Accessibility of animal-free antibodies
Coming soon	Commercializing Animal-free Antibodies
Coming soon	Making Animal-free Antibodies Accessible for Academic Research and Testing
Coming soon	Exploring the Use of Alternative Binders in the Laboratory

ASCCT Webinars(ASCCT/ESTIV)

Update	Title
2020.8.31	Use of New Approach Methodologies for Cosmetic Safety Assessment without Animal Testing
2021.6.24	International Computational Collaborations for Predictive Toxicology
2020.8.31	The Use of Machine Learning and Artificial Intelligence in Toxicology and Risk Assessment
2020.8.31	Human Biology-based Approaches for COVID 19 Therapeutics
2020.8.31	PubMed Abstract Sifter: A Literature Informatics Tool for Chemical Research
2020.9.30	Phenotypic profiling for high-throughput chemical screening at the U.S. EPA
2020.12.11	Development of a Bayesian Network Model for Predicting Fish Acute Toxicity from Fish Embryo Toxicity Data
2021.2.2	Medical Device Assessment: Updates for Thrombogenicity and Skin Irritation
2021.3.5	QIVIVE Tools and Case Studies
2021.5.18	Legal and Policy Considerations for the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment
2021.6.15	New Approach Methods in genotoxicity and mechanistic toxicity testing for the animal-free safety assessment of novel pharmaceuticals and chemicals
2021.7.7	Human Induced Pluropotent Stem Cells (hIPSC) in Toxicology
2021.7.27	Bridging toxicology and research: COVID-19 initiatives
2021.11.3	EU REACH Regulation, EU Cosmetic Regulation, and New Animal Tests on Cosmetic Ingredients
2021.12.7	Organs-on-Chips: New science and standards for implementation

The Innovative (In vitro) Cell-based Assays for Drug Discovery (Xconomy Insight/Eurofins Discovery)

Update	Title
2021.1.19	Challenges of Incorporating Non-Animal Preclinical Data into Drug Regulatory Applications
2021.2.18	Screening Approaches for Reducing Attrition Due to Drug-induced Liver Injury (DILI) Early in Drug Discovery
2021.2.9	High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes

NC3Rs Webinar

Update	Title
2021.2.3	Scientific validity and EURL ECVAM recommendations for the replacements for animal-derived antibodies
2021.2.17	Organ-on-a-chip technology-from a scientific and 3Rs perspective

ICCVAM Communities of Practice Webinar: Non-animal Approaches for Mixtures Assessment

Update	Title
2021.2.23	ICCVAM Communities of Practice Webinar: Non-animal Approaches for Mixtures Assessment

Webinar on Inhalation Toxicity Testing (PSCI, US EPA)

Update	Title
2021.2.25	2020 Webinar on Inhalation Toxicity Testing
2021.6.11	2021 Webinar on Inhalation Toxicity Testing

Microphysiological Systems for COVID Research(NICEATM, NC3Rs)

Update	Title
2021.3.17	MPSCoRe Organizational Meeting: January 2021
2021.5.31	MPSCoRe Spring Workshop: April 2021

IVAM Webinar Series: The development and application of in vitro methods and non-animal models for toxicology and product safety

Update	Title
2021.3.25	Big Data and Toxicology - Future is Now -A.I. and Big Data - New Kids on the Toxicology Block -Smart Chemistry - Algorithms for Chemical Classification and Clustering
2021.6.8	State of the Science: QSAR Modeling of Skin Sensitization -Pred-Skin: A Web Portal for Accurate Prediction of Human Skin Sensitizers -Evaluation of the Global Performance of Eight In Silico Skin Sensitization Models -Skin Sensitization In Silico Protocol

Gaining Acceptance in Next Generation PBK Modelling Approaches for Regulatory Assessments(OECD)

Update	Title
2021.5.19	Gaining Acceptance in Next Generation PBK Modelling Approaches for Regulatory Assessments

Updates on Activities Related to 21st Century Toxicology(CAAT, AFSA)

Update	Title
2021.6.3	Updates on Activities Related to 21st Century Toxicology

PSIS 2021 Online Workshop - Organ on Chip: Towards Standardization(JRC, CEN, CENELEC)

Update	Title
2021.6.9	PSIS 2021 Online Workshop - Organ on Chip: Towards Standardization

NC3Rs「10 years of CRACK IT」

Update	Title
2021.11.2	NC3Rs「10 years of CRACK IT」 -The worm that turned the tide on in vivo DART testing -Virtual laboratories for non-animal disease research and toxicity testing -Chipping away at in vivo nephrotoxicity testing -Putting in vitro platforms at the heart of cardiotoxicity testing -3D retinal organoids - a vision of the future -Using microfluidics to eliminate surgical embryo transfer in mice -Assessing the genotoxic potential of gene therapy products in vitro(2021.11.17)

Update

Title

2021.11.2

NC3Rs「10 years of CRACK IT」

-The worm that turned the tide on in vivo DART testing
-Virtual laboratories for non-animal disease research and toxicity testing
-Chipping away at in vivo nephrotoxicity testing
-Putting in vitro platforms at the heart of cardiotoxicity testing
-3D retinal organoids - a vision of the future
-Using microfluidics to eliminate surgical embryo transfer in mice
-Assessing the genotoxic potential of gene therapy products in vitro(2021.11.17)

Moving from One-Size-Fits-All to Fit-for Purpose TTC Values (SOT, CTSS)

Update	Title
2021.9.1	Moving from One-Size-Fits-All to Fit-for Purpose TTC Values

「Nix the Six」：Strategies for Implementing a Non-animal Acute 6-Pack (PCRM-NURA)

Update	Title
2021.11.22	Oral and Dermal Toxicity
2021.11.22	Dermal Sensitization
2021.11.22	Skin and Eye Irritation
2021.11.22	Inhalation Toxicity
2021.11.22	Opportunities and Outlook

ICCVAM Public Forum

Update	Title
2020.5.21	ICCVAM Public Forum 2020 -Welcome and Introductions -Reflections on 20 Years of ICCVAM -ICCVAM Workgroup Updates -NICEATM Update -Update on FDA Activities on Alternative Methods -IATA for Developmental Neurotoxicity -Update on Alternatives Research Activities at EPA -EPA Office of Pesticide Programs -Update from EPA/OSCPP/OPPT -USDA Animal Welfare Information Center -59MDW Science and Technology Overview and Upcoming Toxicology Projects -OSHA Update to ICCVAM -NCATS Update on Tox21 Activities -Measurement Science Activities Under ICCVAM -OECD Test Guidelines Programme Update
2021.7.20	ICCVAM Public Forum 2021 -Welcome and Introductions -NICEATM and NTP Update -ICCVAM Workgroup Updates -Consumer Product Safety Commission Guidance for Industry and Test Method Developers -USDA Animal Welfare Information Center -Application of NAMs, Surrogates, and Read-across in Rapid Development of PBPK Models for Human Health Risk Assessment -Investigation of Parathion-induced Neurotoxicity in SHSY5Y Cells Demonstrates Utility of the Assay as an Alternative Animal Model -Assessment of Acute Oral Toxicity for Mixtures Using In Silico Modeling Methods -Alternative Approaches to Ecotoxicological Testing and Assessment -Impact of Alternatives to Animals in VA Research -Update on EPA ORD New Approach Method Research Activities -Recent Progress Towards Reducing Animal Use & Adopting NAMs at EPA's Office of Pesticide Programs -OPPT's Progress Implementing the Near-term Activities in the TSCA Strategic Plan -Advancing Alternative Methods at FDA -Measurement Science Activities Under ICCVAM -OECD Test Guidelines Programme Update

Update

Title

2020.5.21

ICCVAM Public Forum 2020

-Welcome and Introductions
-Reflections on 20 Years of ICCVAM
-ICCVAM Workgroup Updates
-NICEATM Update
-Update on FDA Activities on Alternative Methods
-IATA for Developmental Neurotoxicity
-Update on Alternatives Research Activities at EPA
-EPA Office of Pesticide Programs
-Update from EPA/OSCPP/OPPT
-USDA Animal Welfare Information Center
-59MDW Science and Technology Overview and Upcoming Toxicology Projects
-OSHA Update to ICCVAM
-NCATS Update on Tox21 Activities
-Measurement Science Activities Under ICCVAM
-OECD Test Guidelines Programme Update

2021.7.20

ICCVAM Public Forum 2021

-Welcome and Introductions
-NICEATM and NTP Update
-ICCVAM Workgroup Updates
-Consumer Product Safety Commission Guidance for Industry and Test Method Developers
-USDA Animal Welfare Information Center
-Application of NAMs, Surrogates, and Read-across in Rapid Development of PBPK Models for Human Health Risk Assessment
-Investigation of Parathion-induced Neurotoxicity in SHSY5Y Cells Demonstrates Utility of the Assay as an Alternative Animal Model
-Assessment of Acute Oral Toxicity for Mixtures Using In Silico Modeling Methods
-Alternative Approaches to Ecotoxicological Testing and Assessment
-Impact of Alternatives to Animals in VA Research
-Update on EPA ORD New Approach Method Research Activities
-Recent Progress Towards Reducing Animal Use & Adopting NAMs at EPA's Office of Pesticide Programs
-OPPT's Progress Implementing the Near-term Activities in the TSCA Strategic Plan
-Advancing Alternative Methods at FDA
-Measurement Science Activities Under ICCVAM
-OECD Test Guidelines Programme Update

WC11 Webinars on 3Rs in COVID-19 Research

Update	Title
2020.9.4	8⁄25 Webinars -Coronavirus Research - Anything Goes? -Animal Models and Alternatives for COVID-19 Research -Research Response of the European Commission to Address the COVID-19 Pandemic
2020.9.4	8⁄26 Webinars -COVID-19 – What is in the Box of Alternative Methods?? -Human Pluripotent Stem Cell Models for COVID-19 Disease Modeling and Drug Screening -3Rs and COVID-19 Vaccine Development: Regulatory Aspects

3Rs across Europe webinar series 2020

Update	Title
2020.10.16	9⁄22 Webinars -Organoids and Single Cell Analyses as Tools to Substitute Mouse Models in Cancer Research -Pain management and assessment in mouse femoral fracture models -BEHAVE: Developing a toolkit for deep-behavior profiling of laboratory rodents -Fish cell lines and the 3Rs: fundamental developments and application in chemical risk assessment
2020.10.16	9⁄23 Webinars -Supraglottic airway devices as a means of refining laboratory animal anaesthesia -Development of a new in vitro metastasis assay -An in vitro method to predict sudden adverse lung effects -QSAR modeling of chemical substances’ possible interference with the thyroid hormone system
2020.10.16	9⁄24 Webinars -A guideline for marking and tagging fish -Let your digital twin become your own personalized guinea pig -Developing a complex model of bone formation -Reducing the use of animals for studying transmission of respiratory viruses

Conference on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing(U.S. EPA)

Update	Title
2020.12.2	10⁄19 Webinars -Overview of EPA NAMs Work Plan -Progress on Implementing the TSCA Alternatives Strategic Plan -Using Chemical, Biological, and In Vivo Data for NAMs: Which data do we have, and what can we do with it? -Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility -Drugmonizome and Drugmonizome-ML: Integration and Abstraction of Small Molecule Attributes for Drug Set Enrichment Analysis and Machine Learning -"Fit for Purpose" for Organotypic Models in Environmental Health Protection
2020.12.2	10⁄20 Webinars -Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence -In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps -An OECD Harmonized Template (OHT) to Report NAM Results in Regulatory Environments: Principles and Practical Use -Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity -Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients -Case Study #3: Incorporating the Threshold of Toxicological Concern into Regulatory Decisions under the Amended Toxic Substances Control Act

Update

Title

2020.12.2

10⁄19 Webinars

-Overview of EPA NAMs Work Plan
-Progress on Implementing the TSCA Alternatives Strategic Plan
-Using Chemical, Biological, and In Vivo Data for NAMs: Which data do we have, and what can we do with it?
-Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility
-Drugmonizome and Drugmonizome-ML: Integration and Abstraction of Small Molecule Attributes for Drug Set Enrichment Analysis and Machine Learning
-"Fit for Purpose" for Organotypic Models in Environmental Health Protection

2020.12.2

10⁄20 Webinars

-Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence
-In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps
-An OECD Harmonized Template (OHT) to Report NAM Results in Regulatory Environments: Principles and Practical Use
-Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity
-Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients
-Case Study #3: Incorporating the Threshold of Toxicological Concern into Regulatory Decisions under the Amended Toxic Substances Control Act

International Symposium on Alternatives Assessment: Current Practices and Future Prospects

Update	Title
2021.1.4	10⁄27 Webinars -Updates from Europe Part I: Programs advancing informed substitution -Industry experience implementing alternatives assessment and substitution Part I: Lessons learned from large multi-nationals
2021.1.4	10⁄28 Webinars -Updates from Europe Part II: Safe-By-Design -Industry experience implementing alternatives assessment and substitution Part II: Lessons learned from small business users of chemicals
2021.1.4	10⁄29 Webinars -Part I: Considering Uncertainty: Real-world strategies to make decisions -Part II: Considering Trade-offs: Real-world strategies to make decisions(no video)

The 7th Annual 3Rs Symposium: Practical Solutions and Success Stories (AWIC, OLAW, JHMI-MCP, CAAT)

Update	Title
2021.1.5	Minibrain Organoids
2020.1.5	Innovative Models in Biomedical Research: A Literature Review
2020.1.5	Other

2021, 8th Annual 3Rs Symposium: Pandemic-Driven Advances (AWIC, OLAW, CAAT, NAL)

Update	Title
2021.9.8	NCATS: NIH: Translating Disruptive Technologies from Microphysiological Systems to Electronic Noses
2021.9.8	Redefining Facility Operations & the Utilization of Performance Standards in Animal Husbandry & Care
2021.9.8	How COVID Spotlights the Model Dilemma in Biomedical Research
2021.9.8	Harmonizing Coronavirus Research Across NPRCs: Coronavirus Vaccine & Therapeutic Evaluation Network
2021.9.8	Elements of a Systematic Process for Literature Searching: a 3Rs-based Example
2021.9.8	The Evolution of the 3Rs: Reflections on Art, Ethics, and Science
2021.9.8	Facial Cues for Assessing Welfare in Primates
2021.9.8	Ally or Enemy: Machine Learning and the 3Rs
2021.9.8	Assessing Pain in Small Laboratory Rodents to Improve Animal Welfare
2021年9月8日	Measuring and Enhancing Welfare through Voluntary Training Tasks

Microphysiological Systems: Bridging Human and Animal Research - A Workshop (NASEM, ILAR)

Update	Title
2021.2.22	Welcome Remarks
2021.2.22	MPS for Toxicology Testing
2021.2.22	Going from In Vitro to In Silico - Data and Developmental Tools
2021.2.22	Panel Discussion on Topics of Public Health Importance (COVID)/a>
2021.2.22	Commercialization / Engineering / Collaborations
2021.2.22	Multi-Organ Chips and Emerging Application for Biologics Studies
2021.2.22	Closing Remarks

The collection of webinar videos is efforted for the promotion of alternative methods. The copyright of webinar videos belongs to whose original providers.